Patents by Inventor Andrew Kuhn

Andrew Kuhn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9499858
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Grant
    Filed: January 11, 2013
    Date of Patent: November 22, 2016
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
  • Publication number: 20150152473
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Application
    Filed: January 11, 2013
    Publication date: June 4, 2015
    Applicant: BECTON, DICKINSON AND COMPANY
    Inventors: James G. Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
  • Patent number: 8708942
    Abstract: A custom ankle brace system is disclosed which is constructed from a low temperature non-olefinic elastomeric blend material, and methods of fabricating and fitting the same. This material can be molded directly to a custom mold made from a casting of an affected body part. The final product will be an ankle brace that is able to be heated at low temperature (150° F.-200° F.) by use of an oven or equivalent, and custom molded directly on the patient. If necessary reheated, the ankle brace may be remolded to account for a change in the patient's anatomy or for an increase in comfort.
    Type: Grant
    Filed: February 10, 2010
    Date of Patent: April 29, 2014
    Inventor: Jeffrey Andrew Kuhn
  • Patent number: 8372605
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Grant
    Filed: March 25, 2011
    Date of Patent: February 12, 2013
    Assignee: Becton, Dickinson and Company
    Inventors: James Nadeau, Tobin J. Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha-Sha Wang, Keith Edward Thornton
  • Publication number: 20110244457
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Application
    Filed: March 25, 2011
    Publication date: October 6, 2011
    Applicant: Becton, Dickinson and Company
    Inventors: James Nadeau, Tobin Hellyer, Dolores M. Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Sha Wang, Keith Thornton
  • Publication number: 20110196276
    Abstract: A custom ankle brace system is disclosed which is constructed from a low temperature non-olefinic elastomeric blend material, and methods of fabricating and fitting the same. This material can be molded directly to a custom mold made from a casting of an affected body part. The final product will be an ankle brace that is able to be heated at low temperature (150° F.-200° F.) by use of an oven or equivalent, and custom molded directly on the patient. If necessary reheated, the ankle brace may be remolded to account for a change in the patient's anatomy or for an increase in comfort.
    Type: Application
    Filed: February 10, 2010
    Publication date: August 11, 2011
    Inventor: Jeffrey Andrew Kuhn
  • Patent number: 7932060
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte.
    Type: Grant
    Filed: April 19, 2004
    Date of Patent: April 26, 2011
    Assignee: Becton, Dickinson and Company
    Inventors: James Nadeau, Tobin Hellyer, Dolores Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Sha Wang, Keith Thornton
  • Publication number: 20050009050
    Abstract: A high-sensitivity, low-background immuno-amplification assay is provided, which offers a streamlined workflow suitable for high-throughput assays of clinically relevant samples, such as blood and other bodily fluids. The assay comprises the use of two proximity members that each comprise an analyte-specific binding component conjugated to an oligonucleotide. Binding an analyte brings the oligonucleotide moieties of the proximity members in sufficiently close contact that the oligonucleotides form an amplicon. The presence of the analyte then is detected through amplification of the amplicon and detection of the amplified nucleic acids. The sensitivity of the assay of the present invention is improved by preventing spurious or non-specific amplicon formation by proximity members that are not complexed with an analyte. In one embodiment, target-independent amplicon formation is prevented by using hybridization blocker oligonucleotides that bind oligonucleotide moieties that are not hybridized to each other.
    Type: Application
    Filed: April 19, 2004
    Publication date: January 13, 2005
    Inventors: James Nadeau, Tobin Hellyer, Dolores Berger, William Nussbaumer, Robert Rosenstein, Andrew Kuhn, Sha Wang, Keith Thornton